Title:
BI-SPECIFIC MONOVALENT DIABODIES THAT ARE CAPABLE OF BINDING TO GPA33 AND CD3, AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2015/026894
Kind Code:
A3
Abstract:
The present invention is directed to bi-specific monovalent diabodies that comprise two polypeptide chains and which possess at least one binding site specific for an epitope of CD3 and one binding site specific for an epitope of gpA33 (i.e., a "gpA33 x CD3 bi-specific monovalent diabody"). The present invention also is directed to bi-specific monovalent diabodies that comprise an immunoglobulin Fc Domain ("bi- specific monovalent Fc diabodies") and are composed of three polypeptide chains and which possess at least one binding site specific for an epitope of gpA33 and one binding site specific for an epitope of CD3 (i.e., a "gpA33 x CD3 bi-specific monovalent Fc diabody"). The bi-specific monovalent diabodies and bi-specific monovalent Fc diabodies of the present invention are capable of simultaneous binding to gpA33 and CD3. The invention is directed to pharmaceutical compositions that contain such bi-specific monovalent diabodies or such bi-specific monovalent Fc diabodies. The invention is additionally directed to methods for the use of such diabodies in the treatment of cancer and other diseases and conditions.
More Like This:
WO2008013454 | IMMUNOGENIC COMPOUNDS AND PROTEIN MIMICS |
WO/2019/225787 | ANTI-B7-H3 ANTIBODY AND USE THEREOF |
JP2014039551 | VIRUS CODING FOR MUTANT MEMBRANE PROTEIN |
Inventors:
MOORE PAUL A (US)
LI JONATHAN (US)
CHEN FRANCINE ZHIFEN (US)
JOHNSON LESLIE S (US)
SHAH KALPANA (US)
BONVINI EZIO (US)
LI JONATHAN (US)
CHEN FRANCINE ZHIFEN (US)
JOHNSON LESLIE S (US)
SHAH KALPANA (US)
BONVINI EZIO (US)
Application Number:
PCT/US2014/051793
Publication Date:
April 16, 2015
Filing Date:
August 20, 2014
Export Citation:
Assignee:
MACROGENICS INC (US)
International Classes:
A61K39/00; C07K16/00; C12P21/08
Domestic Patent References:
WO2012162067A2 | 2012-11-29 |
Foreign References:
US20070004909A1 | 2007-01-04 | |||
US20040082039A1 | 2004-04-29 | |||
US20030229208A1 | 2003-12-11 | |||
US20120184716A1 | 2012-07-19 | |||
US20020193571A1 | 2002-12-19 | |||
US20100174053A1 | 2010-07-08 | |||
US20100196372A1 | 2010-08-05 | |||
US20120289418A1 | 2012-11-15 |
Other References:
See also references of EP 3035956A4
Attorney, Agent or Firm:
AUERBACH, Jeffrey, I et al. (2200 Research Blvd. Suite 56, Rockville MD, US)
Download PDF:
Previous Patent: PREDICTIVE BIOMARKERS FOR METABOLIC SYNDROME
Next Patent: LIGHTS ON A TRACK WITH BRAKING FEATURE
Next Patent: LIGHTS ON A TRACK WITH BRAKING FEATURE